BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 15, 2017
View Archived Issues
ProMIS Neurosciences selects third lead product for Alzheimer's disease
Read More
TLD-1633 demonstrates increased efficacy in glioblastoma multiforme cell line
Read More
Phase II results presented for tezepelumab in adults with uncontrolled asthma
Read More
First data on AZD-7594 in asthma patients disclosed
Read More
Daiichi Sankyo and MD Anderson enter AML research collaboration
Read More
Halozyme Therapeutics licenses its Enhanze drug-delivery technology to Roche
Read More
Collaborations Pharmaceuticals receives NIH award to repurpose drug for Chagas disease
Read More
Nemiralisib delivered via ELLIPTA device found to be safe and well tolerated
Read More
Harvard's Wyss Institute launches human Organ Chip project
Read More
Independent DMC recommends discontinuation of Prostvac phase III study in mCRPC
Read More
FDA approves Aliqopa for relapsed follicular lymphoma
Read More
Briviact monotherapy approved in U.S. for partial-onset seizures in adults
Read More
RDD Pharma wins grant to test RDD-0315 for fecal incontinence in SCI patients
Read More
Janssen files sNDA for Zytiga for earlier stages of metastatic prostate cancer
Read More
NovoBiotic Pharmaceuticals patents novel macrocyclic antibiotics
Read More
FDA expands indication for Sunovion's Aptiom
Read More
Bristol-Myers Squibb and Halozyme announce agreement to use Enhanze technology in immuno-oncology
Read More
Shenzhen Targetrx Biotechnology discloses IDO inhibitors
Read More
FDA grants expanded approval to Afluria Quadrivalent influenza vaccine
Read More
RET inhibitors disclosed in GlaxoSmithKline patent
Read More
EMA committee recommends approval of Trelegy Ellipta for COPD
Read More
Phase III PROSPER study in patients with nonmetastatic CRPC meets primary endpoint
Read More
Alios BioPharma presents FXR agonists for NASH
Read More
ALK-Abello reports data from phase III study of tree allergy SLIT tablets
Read More
Bayer Pharma divulges BRD4 inhibitors for cancer
Read More
FDA approves bevacizumab biosimilar Mvasi
Read More
Celgene studies CC-90010 in advanced solid tumors and relapsed or refractory NHL
Read More
MEDI-4166 shows safety in type 2 diabetes subjects
Read More
FDA approves Privigen to treat chronic inflammatory demyelinating polyneuropathy in adults
Read More
Da Volterra and Bioaster present beta-lactamase variants
Read More
